SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-14-002435
Filing Date
2014-11-14
Accepted
2014-11-14 16:21:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g07422sun_11102014.htm SC 13G 194273
2 ex991to13g07422sun_11102014.htm EX-99.1 27846
  Complete submission text file 0000921895-14-002435.txt   223830
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address ONE SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 141224494
SIC: 2834 Pharmaceutical Preparations